According to Apellis Pharmaceuticals's latest financial reports the company's current earnings are HK$0.78 Billion. , an increase over its 2023 earnings that were of -HK$4.1 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.